180
Views
1
CrossRef citations to date
0
Altmetric
Editorials

Artificial Intelligence in Cancer Clinical Research: II. Development and Validation of Clinical Prediction Models

ORCID Icon &

References

  • Lyman GH, Kuderer NM. Artificial intelligence in cancer clinical research: I. Introduction. Cancer Invest. 2024;2024:1–4. doi:10.1080/07357907.2024.2347784.
  • Altman DG, Lyman GH. Methodological challenges in the evaluation of prognostic factors in breast cancer. Breast Cancer Res Treat. 1998;52(1–3):289–303. doi:10.1023/a:1006193704132.
  • Rydzewski NR, Dinakaran D, Zhao SG, Ruppin E, Turkbey B, Citrin DE, Patel KR. Comparative evaluation of LLMs in clinical oncology. Nejm Ai. 2024;1(5):1–11. doi:10.1056/AIoa2300151.
  • Szolovits z. Large language models seem miraculous, but science abhors miracles. Nejm Ai. 2024;2024:103 doi:10.1056/AIp2300103.
  • Rösler W, Altenbuchinger M, Baeßler B, Beissbarth T, Beutel G, Bock R, et al. An overview and a roadmap for artificial intelligence in hematology and oncology. J Cancer Res Clin Oncol. 2023;149(10):7997–8006. doi:10.1007/s00432-023-04667-5.
  • Liao J, Li X, Gan Y, Han S, Rong P, Wang W, et al. Artificial intelligence assists precision medicine in cancer treatment. Front Oncol. 2022;12:998222. doi:10.3389/fonc.2022.998222.
  • Seyyed-Kalantari L, Zhang H, McDermott MBA, Chen IY, Ghassemi M. Underdiagnosis bias of artificial intelligence algorithms applied to chest radiographs in under-served patient populations. Nat Med. 2021;27(12):2176–2182. doi:10.1038/s41591-021-01595-0.
  • Lyman GH, Msaouel P, Kuderer NM. Risk model development and validation in clinical oncology: lessons learned. Cancer Invest. 2023;41:1–11.
  • Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;385(4):e078378–g7594. doi:10.1136/bmj.g7594.
  • Collins GS, Dhiman P, Andaur Navarro CL, Ma J, Hooft L, Reitsma JB, et al. Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence. BMJ Open. 2021;11(7):e048008. doi:10.1136/bmjopen-2020-048008.
  • Dhiman P, Ma J, Andaur Navarro CL, Speich B, Bullock G, Damen JAA, et al. Risk of bias of prognostic models developed using machine learning: a systematic review in oncology. Diagn Progn Res. 2022;6(1):13. doi:10.1186/s41512-022-00126-w.
  • Dhiman P, Ma J, Navarro CA, et al. Reporting of prognostic clinical prediction models based on machine learning methods in oncology needs to be improved. J Clin Epidemiol. 2021;138:60–72.
  • Andaur Navarro CL, Damen JAA, Takada T, Nijman SWJ, Dhiman P, Ma J, et al. Risk of bias in studies on prediction models developed using supervised machine learning techniques: systematic review. BMJ. 2021;375:n2281. doi:10.1136/bmj.n2281.
  • Andaur Navarro CL, Damen JAA, van Smeden M, et al. Systematic review identifies the design and methodological conduct of studies on machine learning-based prediction models. J Clin Epidemiol. 2023;154:8–22.
  • Christodoulou E, Ma J, Collins GS, et al. A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models. J Clin Epidemiol. 2019;110:12–22.
  • Andaur Navarro CL, Damen JAA, Takada T, et al. Systematic review finds "spin" practices and poor reporting standards in studies on machine learning-based prediction models. J Clin Epidemiol. 2023;158:99–110.
  • Dhiman P, Ma J, Andaur Navarro CL, et al. Overinterpretation of findings in machine learning prediction model studies in oncology: a systematic review. J Clin Epidemiol. 2023;157:120–133.
  • Andaur Navarro CL, Damen JAA, Takada T, Nijman SWJ, Dhiman P, Ma J, et al. Completeness of reporting of clinical prediction models developed using supervised machine learning: a systematic review. BMC Med Res Methodol. 2022;22(1):12. doi:10.1186/s12874-021-01469-6.
  • Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, et al. TRIPOD + AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378. doi:10.1136/bmj-2023-078378.
  • Gichoya JW, Thomas K, Celi LA, et al. AI pitfalls and what not to do: mitigating bias in AI. Br J Radiol. 2023;96:20230023.
  • Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366(6464):447–453. doi:10.1126/science.aax2342.
  • Adler-Milstein J, Redelmeier DA, Wachter RM. The limits of clinician vigilance as an AI safety Bulwark. Jama. 2024;331(14):1173–1174. doi:10.1001/jama.2024.3620.
  • Liu Y, Chen P-HC, Krause J, Peng L. How to read articles that use machine learning: users’ guides to the medical literature. Jama. 2019;322(18):1806–1816. doi:10.1001/jama.2019.16489.
  • Cabral S, Restrepo D, Kanjee Z, Wilson P, Crowe B, Abdulnour R-E, et al. Clinical reasoning of a generative artificial intelligence model compared with physicians. JAMA Intern Med. 2024;184(5):581–583. doi:10.1001/jamainternmed.2024.0295.
  • Clift AK, Dodwell D, Lord S, Petrou S, Brady M, Collins GS, et al. Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study. BMJ. 2023;381:e073800. doi:10.1136/bmj-2022-073800.
  • Damen JAA, Moons KGM, van Smeden M, et al. How to conduct a systematic review and meta-analysis of prognostic model studies. Clin Microbiol Infect. 2023;29:434–440.
  • Levis B, Snell KIE, Damen JAA, Hattle M, Ensor J, Dhiman P, et al. Risk of bias assessments in individual participant data meta-analyses of test accuracy and prediction models: a review shows improvements are needed. J Clin Epidemiol. 2024;165:111206.
  • Dhiman P, Ma J, Andaur Navarro CL, Speich B, Bullock G, Damen JAA, et al. Methodological conduct of prognostic prediction models developed using machine learning in oncology: a systematic review. BMC Med Res Methodol. 2022;22(1):101. doi:10.1186/s12874-022-01577-x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.